Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 13, 2018

SELL
$26.84 - $39.14 $1.1 Million - $1.61 Million
-41,039 Closed
0 $0
Q3 2017

Nov 09, 2017

BUY
$29.49 - $38.37 $1.21 Million - $1.57 Million
41,039
41,039 $1.55 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.76B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Dai Ichi Life Insurance Company, LTD Portfolio

Follow Dai Ichi Life Insurance Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dai Ichi Life Insurance Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dai Ichi Life Insurance Company, LTD with notifications on news.